SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654954-19-012042
Filing Date
2019-10-28
Accepted
2019-10-28 16:35:20
Documents
3
Period of Report
2019-12-19

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT azrxpre14a_oct2019.htm PRE 14A 561952
2 IMAGE azrxpre14a_oct2019000.jpg GRAPHIC 2939
3 IMAGE azrxpre14a_oct2019001.jpg GRAPHIC 3862
  Complete submission text file 0001654954-19-012042.txt   572740
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: PRE 14A | Act: 34 | File No.: 001-37853 | Film No.: 191173386
SIC: 2834 Pharmaceutical Preparations